Andrea Brinkmann
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Immune Cell Function and Interaction, Neuroblastoma Research and Treatments, Virus-based gene therapy research, CAR-T cell therapy research
Most-Cited Works
- → Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1(2006)1,183 cited
- → IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion(2010)101 cited
- → IL‐2‐activated haploidentical NK cells restore NKG2D‐mediated NK‐cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA(2010)83 cited
- → ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3− NK cells(2007)26 cited
- → Expression von AC133 vs. CD34 bei akuten Leukämien im Kindesalter*(2000)8 cited
- → Long-Term Follow-Up of Patients Treated by Gene Therapy for X-Linked Chronic Granulomatous Disease.(2005)2 cited
- → Expression of AC133 in Childhood Acute Leukemia(2001)
- → Characterizing the physical abuse experiences of young adolescents(2014)
- → CD133/CD34 Expression on Hematopoietic Stem-/Progenitor Cells and Acute Leukemic Blasts(2003)